Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by 2O2Ovisionon Nov 28, 2024 2:10pm
171 Views
Post# 36335961

RE:Latest insiders activity

RE:Latest insiders activityThanks for flagging that. Nice to see they're finally clearing up the filings from options that expired in 2023. We'll see how many new ones they replace them with shortly but interestingly, they haven't yet used the ATM even with the pump last month (as of nov 9 anyway). I can't remember them ever missing a chance to sell into it, i.e. the 2.6M shares just over a buck this spring on those small spikes. Now the MM's have tripled the shorts with no dump to cover as per every other pump and dump. Tax loss selling should aleviate some of that so we'll see what happens. As of last week CGAR was still posting that they're working on their protocol so maybe we'll hear about that soon to turns the algos around. I think everyone is starved for news, or maybe it's stuck in the mail LOL
<< Previous
Bullboard Posts
Next >>